Eurican P inj. susp. (lyoph.) i.m./s.c./i.v. vial
Country: Belgium
Language: English
Source: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
Canine Parvovirus
Available from:
Boehringer Ingelheim Animal Health Belgium (DECOMMISSIONED) SA-NV
ATC code:
QI07AD01
INN (International Name):
Canine Parvovirus
Pharmaceutical form:
Lyophilisate for suspension for injection
Composition:
Canine Parvovirus
Administration route:
Intramuscular use; Intravenous use; Subcutaneous use
Therapeutic group:
dog
Therapeutic area:
Canine Parvovirus
Product summary:
CTI code: 125221-01 - Pack size: 10 x 1 dose - Commercialisation status: YES - CNK code: 1077585 - Delivery mode: Medical prescription
Authorization status:
Commercialised: No
Authorization date:
1983-12-27
